Anti-fibrotic effect of NV556, a sanglifehrin-based cyclophilin inhibitor, in a preclinical model of non-alcoholic steatohepatitisA. Grönberg,E. Elmér,Matthew Alan Gregory,Steven James Moss,M. HanssonJOURNAL OF HEPATOLOGY(2017)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要